Skip to main content
Multiple Myeloma
Patient and Caregiver Preferences for RRMM Treatment Should Be Considered Using Shared Decision-Making
Read More
Multiple Myeloma
Ciltacabtagene Autoleucel Shows Promising Results in Patients with Multiple Myeloma Who Have Experienced Early Clinical Relapse
Read More
Multiple Myeloma
Updated Results from IKEMA Demonstrate a Median PFS of Nearly 3 Years with Isa-Kd
Read More
Multiple Myeloma
Daratumumab + Cyclophosphamide, Bortezomib, and Dexamethasone Induction Followed by Daratumumab Maintenance Achieved Durable Responses in Patients with RRMM and NDMM
Read More
Multiple Myeloma
Addition of ASCT to Triplet Induction and Lenalidomide Maintenance to Progression: Results from the DETERMINATION Trial
Read More
Page 3 of 3
Results 21 - 25 of 25